Stay updated on Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial
Sign up to get notified when there's something new on the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page.

Latest updates to the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for a ZX008 (fenfluramine) study in children and young adults with Dravet or Lennox-Gastaut syndrome who take cannabidiol. It includes the study’s design, participation criteria, locations, measured outcomes, and completed status.SummaryDifference41%

- Check16 days agoChange DetectedThe 403 error page was replaced by a mostly blank study-record page, and the site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.6%

- Check22 days agoChange DetectedA site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details. This indicates blocked access to the record rather than a content update.SummaryDifference17%

Stay in the know with updates to Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page.